Published in
Taylor and Francis Group, Leukemia & Lymphoma, 9(63), p. 2126-2135, 2022
DOI: 10.1080/10428194.2022.2062347
Links
Tools
Continuous induction with lenalidomide/dexamethasone versus autologous stem cell transplantation in newly diagnosed multiple myeloma: a case for response-adapted approach
Journal article published in 2022 by
Oscar B. Lahoud,
Heather Landau 
,
James Nguyen,
Sean Devlin,
Nikoletta Lendvai,
Jonathan Weltz,
Tumininu Ayorinde,
David J. Chung,
Alexander M. Lesokhin ,
Tarun Kewalramani,
Neha Korde,
Sham Mailankody,
Ola Landgren,
Sergio Giralt,
Raymond L. Comenzo
and other authors.
,
James Nguyen,
Sean Devlin,
Nikoletta Lendvai,
Jonathan Weltz,
Tumininu Ayorinde,
David J. Chung,
Alexander M. Lesokhin ,
Tarun Kewalramani,
Neha Korde,
Sham Mailankody,
Ola Landgren,
Sergio Giralt,
Raymond L. Comenzo
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 